ATLANTA, April 21, 2022 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading health and human services provider to the federal government, today announced it has been awarded a contract to continue providing epidemiologic and public health support to the National Institute of Diabetes and Digestive and Kidney Diseases (“NIDDK”). NIDDK is an institute of the National Institutes of Health (“NIH”). DLH has held this work since this contract was first awarded in 1987.
DLH Wins Renewal of National Institute of Health Contract for Epidemiologic and Public Health Support
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.
